SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Y-mAbs Therapeutics, Inc. – ‘8-K’ for 9/22/22 – ‘XML’

On:  Monday, 9/26/22, at 4:10pm ET   ·   For:  9/22/22   ·   Accession #:  1104659-22-102987   ·   File #:  1-38650

Previous ‘8-K’:  ‘8-K’ on / for 9/26/22   ·   Next:  ‘8-K’ on / for 10/3/22   ·   Latest:  ‘8-K’ on / for 5/7/24   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/26/22  Y-mAbs Therapeutics, Inc.         8-K:5       9/22/22   10:187K                                   Toppan Merrill/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 5: R1          Cover                                               HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- tm2226628d1_8k_htm                  XML     15K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- ymab-20220922_lab                     XML     96K 
 4: EX-101.PRE  XBRL Presentations -- ymab-20220922_pre              XML     64K 
 2: EX-101.SCH  XBRL Schema -- ymab-20220922                         XSD     12K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    32K 
10: ZIP         XBRL Zipped Folder -- 0001104659-22-102987-xbrl      Zip     16K 


‘XML’   —   XBRL Instance — tm2226628d1_8k_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="ymab-20220922.xsd" xlink:type="simple"/>
<context id="From2022-09-22to2022-09-22">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001722964 </identifier>
</entity>
<period>
<startDate> 2022-09-22 </startDate>
<endDate> 2022-09-22 </endDate>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<dei:EntityCentralIndexKey contextRef="From2022-09-22to2022-09-22"> 0001722964 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="From2022-09-22to2022-09-22"> false </dei:AmendmentFlag>
<dei:DocumentType contextRef="From2022-09-22to2022-09-22"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="From2022-09-22to2022-09-22"> 2022-09-22 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="From2022-09-22to2022-09-22"> Y-MABS THERAPEUTICS, INC. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="From2022-09-22to2022-09-22"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="From2022-09-22to2022-09-22"> 001-38650 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="From2022-09-22to2022-09-22"> 47-4619612 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="From2022-09-22to2022-09-22"> 230 Park Avenue </dei:EntityAddressAddressLine1>
<dei:EntityAddressAddressLine2 contextRef="From2022-09-22to2022-09-22"> Suite 3350 </dei:EntityAddressAddressLine2>
<dei:EntityAddressCityOrTown contextRef="From2022-09-22to2022-09-22"> New York </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="From2022-09-22to2022-09-22"> NY </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="From2022-09-22to2022-09-22"> 10169 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="From2022-09-22to2022-09-22"> 646 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="From2022-09-22to2022-09-22"> 885-8505 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="From2022-09-22to2022-09-22"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="From2022-09-22to2022-09-22"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="From2022-09-22to2022-09-22"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="From2022-09-22to2022-09-22"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="From2022-09-22to2022-09-22"> Common Stock, $0.0001 par value </dei:Security12bTitle>
<dei:TradingSymbol contextRef="From2022-09-22to2022-09-22"> YMAB </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="From2022-09-22to2022-09-22"> NASDAQ </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="From2022-09-22to2022-09-22"> false </dei:EntityEmergingGrowthCompany>
</xbrl>


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/27/22  Y-mAbs Therapeutics, Inc.         8-K:5,8,9   4/22/22   11:218K                                   Toppan Merrill/FA
 8/24/18  Y-mAbs Therapeutics, Inc.         S-1                   31:12M                                    Toppan Merrill-FA
Top
Filing Submission 0001104659-22-102987   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 11:32:56.2am ET